Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94398762 | 9439876 | 2 | F | 200611 | 20160714 | 20130805 | 20160722 | EXP | US-SANOFI-AVENTIS-2013SA077684 | AVENTIS | 70.00 | YR | E | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94398762 | 9439876 | 1 | PS | APIDRA | INSULIN GLULISINE | 1 | Subcutaneous | 2F568A | 21629 | SOLUTION FOR INJECTION | TID | ||||||||
| 94398762 | 9439876 | 2 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | N | UNKNOWN | 21081 | SOLUTION FOR INJECTION | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94398762 | 9439876 | 1 | Type 1 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94398762 | 9439876 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94398762 | 9439876 | Blood glucose increased | |
| 94398762 | 9439876 | Cataract | |
| 94398762 | 9439876 | Gait disturbance | |
| 94398762 | 9439876 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94398762 | 9439876 | 1 | 200609 | 0 | ||
| 94398762 | 9439876 | 2 | 200609 | 200810 | 0 |